Predicting Response to Total Neoadjuvant Treatment (TNT) in Locally Advanced Rectal Cancer Based on Multiparametric Magnetic Resonance Imaging: A Retrospective Study

References

• Sauer R , Becker H , Hohenberger W , et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med . 2004;351(17):1731–1740. doi:10.1056/NEJMoa040694 15496622
   PubMed Web of Science ®Google Scholar
• Petrelli F , Trevisan F , Cabiddu M , et al. Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes. Ann Surg . 2020;271(3):440–448. doi:10.1097/SLA.0000000000003471 31318794
   PubMed Web of Science ®Google Scholar
• Wang X , Yu Y , Meng W , et al. Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: a Phase 2 trial. Radiother Oncol . 2018;129(2):300–305. doi:10.1016/j.radonc.2018.08.027 30381141
   PubMed Web of Science ®Google Scholar
• Cercek A , Roxburgh CSD , Strombom P , et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol . 2018;4(6):e180071. doi:10.1001/jamaoncol.2018.0071 29566109
   PubMed Web of Science ®Google Scholar
• Hu YH , Wei JW , Chang H , et al. The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial. Cancer Manag Res . 2018;10:4363–4369. doi:10.2147/CMAR.S168573 30349369
   PubMed Web of Science ®Google Scholar
• Garcia-Aguilar J , Chow OS , Smith DD , et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol . 2015;16(8):957–966. doi:10.1016/S1470-2045(15)00004-2 26187751
   PubMed Web of Science ®Google Scholar
• Bujko K , Wyrwicz L , Rutkowski A , et al. Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized Phase III study. Ann Oncol . 2016;27(5):834–842. doi:10.1093/annonc/mdw062 26884592
   PubMed Web of Science ®Google Scholar
• Gollub MJ , Blazic I , Bates DDB , et al. Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: what are the imaging findings? Eur Radiol . 2019;29(4):1733–1742. doi:10.1007/s00330-018-5726-2 30280248
   PubMed Web of Science ®Google Scholar
• Petrillo A , Fusco R , Granata V , et al. Assessing response to neo-adjuvant therapy in locally advanced rectal cancer using intra-voxel incoherent motion modelling by DWI data and standardized index of shape from DCE-MRI. Ther Adv Med Oncol . 2018;10:1758835918809875. doi:10.1177/1758835918809875 30479672
   PubMed Web of Science ®Google Scholar
• Kim S , Han K , Seo N , et al. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol . 2018;28(12):5231–5240. doi:10.1007/s00330-018-5520-1 29858637
   PubMed Web of Science ®Google Scholar
• Palmisano A , Esposito A , Di Chiara A , et al. Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer? Clin Radiol . 2018;73(6):555–563. doi:10.1016/j.crad.2018.01.007 29459138
   PubMed Web of Science ®Google Scholar
• Lee ES , Kim MJ , Park SC , et al. Magnetic resonance imaging-detected extramural venous invasion in rectal cancer before and after preoperative chemoradiotherapy: diagnostic performance and prognostic significance. Eur Radiol . 2018;28(2):496–505. doi:10.1007/s00330-017-4978-6 28786006
   PubMed Web of Science ®Google Scholar
• Horvat N , Carlos Tavares Rocha C , Clemente Oliveira B , Petkovska I , Gollub MJ . MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics . 2019;39(2):367–387. doi:10.1148/rg.2019180114 30768361
   PubMed Web of Science ®Google Scholar
• Smith NJ , Barbachano Y , Norman AR , Swift RI , Abulafi AM , Brown G . Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg . 2008;95(2):229–236. doi:10.1002/bjs.5917 17932879
   PubMed Web of Science ®Google Scholar
• Chand M , Swift RI , Tekkis PP , Chau I , Brown G . Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer . 2014;110(1):19–25. doi:10.1038/bjc.2013.603 24300971
   PubMed Web of Science ®Google Scholar
• Li J , Wang J , Pang J , Cao S , Chen J , Xu W . Optimized parameters of diffusion-weighted MRI for prediction of the response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Biomed Res Int . 2019;2019:9392747. doi:10.1155/2019/9392747 31737679
   PubMed Web of Science ®Google Scholar
• Liu Z , Zhang XY , Shi YJ , et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res . 2017;23(23):7253–7262. doi:10.1158/1078-0432.CCR-17-1038 28939744
   PubMed Web of Science ®Google Scholar
• Xiao J , Tan Y , Li W , et al. Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: results from a prospective study. Oncol Lett . 2015;9(6):2680–2686. doi:10.3892/ol.2015.3101 26137128
   PubMed Web of Science ®Google Scholar
• Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141–146. doi:10.1111/j.1365-2559.2005.02176.x
   Google Scholar
• Phongkitkarun S , Tohmad U , Larbcharoensub N , Sumbunnanondha K , Swangsilpa T , Sirachainan E . DCE-MRI-derived parameters as predictors of response to neo-adjuvant chemoradiation treatment of rectal carcinoma. J Med Assoc Thai . 2016;99(3):338–347.27276746
   PubMedGoogle Scholar
• Bakke KM , Hole KH , Dueland S , et al. Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival. Acta Oncol . 2017;56(6):813–818. doi:10.1080/0284186X.2017.1287951 28464745
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID , Glynne-Jones R . How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer Treat Rev . 2020;84:101964. doi:10.1016/j.ctrv.2020.101964 32000055
   PubMed Web of Science ®Google Scholar
• Perez K , Safran H , Sikov W , et al. Complete neoadjuvant treatment for rectal cancer: the Brown University oncology group CONTRE Study. Am J Clin Oncol . 2017;40(3):283–287. doi:10.1097/COC.0000000000000149 25374145
   PubMed Web of Science ®Google Scholar
• Gao YH , An X , Sun WJ , et al. Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer. J Surg Oncol . 2014;109(5):478–482. doi:10.1002/jso.23516 24288203
   PubMed Web of Science ®Google Scholar
• Marco MR , Zhou L , Patil S , et al. Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: final results of a multicenter Phase II Trial. Dis Colon Rectum . 2018;61(10):1146–1155. doi:10.1097/DCR.0000000000001207 30192323
   PubMed Web of Science ®Google Scholar
• Martens MH , van Heeswijk MM , van den Broek JJ , et al. Prospective, multicenter validation study of magnetic resonance volumetry for response assessment after preoperative chemoradiation in rectal cancer: can the results in the literature be reproduced? Int J Radiat Oncol Biol Phys . 2015;93(5):1005–1014. doi:10.1016/j.ijrobp.2015.09.008 26581139
   PubMed Web of Science ®Google Scholar
• Zhang C , Ye F , Liu Y , Ouyang H , Zhao X , Zhang H . Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Oncotarget . 2018;9(4):4862–4874. doi:10.18632/oncotarget.23419 29435147
   PubMedGoogle Scholar
• Ren DL , Li J , Yu HC , et al. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World J Gastroenterol . 2019;25(1):118–137. doi:10.3748/wjg.v25.i1.118 30643363
   PubMed Web of Science ®Google Scholar
• Patel UB , Brown G , Machado I , et al. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial. Ann Oncol . 2017;28(2):344–353. doi:10.1093/annonc/mdw616 28426108
   PubMed Web of Science ®Google Scholar
• Meng Y , Wan L , Zhang C , et al. The predictive value of pre-/postneoadjuvant chemoradiotherapy MRI characteristics for patient outcomes in locally advanced rectal cancer. Acad Radiol . 2019.
   Web of Science ®Google Scholar
• Bustamante-Lopez LA , Nahas CSR , Nahas SC , et al. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision. Int J Surg . 2018;56:283–287. doi:10.1016/j.ijsu.2018.07.001 29981939
   PubMed Web of Science ®Google Scholar
• Schurink NW , Lambregts DMJ , Beets-Tan RGH . Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol . 2019;92(1096):20180655. doi:10.1259/bjr.20180655 30433814
   PubMed Web of Science ®Google Scholar
• Chen YG , Chen MQ , Guo YY , Li SC , Wu JX , Xu BH . Apparent diffusion coefficient predicts pathology complete response of rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One . 2016;11(4):e0153944. doi:10.1371/journal.pone.0153944 27100991
   PubMed Web of Science ®Google Scholar
• Blazic IM , Lilic GB , Gajic MM . Quantitative assessment of rectal cancer response to neoadjuvant combined chemotherapy and radiation therapy: comparison of three methods of positioning region of interest for ADC measurements at diffusion-weighted MR Imaging. Radiology . 2017;282(2):418–428. doi:10.1148/radiol.2016151908 27253423
   PubMed Web of Science ®Google Scholar
• Bassaneze T , Goncalves JE , Faria JF , Palma RT , Waisberg J . Quantitative aspects of diffusion-weighted magnetic resonance imaging in rectal cancer response to neoadjuvant therapy. Radiol Oncol . 2017;51(3):270–276. doi:10.1515/raon-2017-0025 28959163
   PubMed Web of Science ®Google Scholar
• Lovinfosse P , Polus M , Van Daele D , et al. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging . 2018;45(3):365–375. doi:10.1007/s00259-017-3855-5 29046927
   PubMed Web of Science ®Google Scholar
• Nie K , Shi L , Chen Q , et al. Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res . 2016;22(21):5256–5264. doi:10.1158/1078-0432.CCR-15-2997 27185368
   PubMed Web of Science ®Google Scholar
• Jeon SH , Song C , Chie EK , et al. Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer. Radiat Oncol . 2019;14(1):43. doi:10.1186/s13014-019-1246-8 30866965
   PubMed Web of Science ®Google Scholar
• Bibault J-E , Giraud P , Housset M , et al. Deep learning and radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer. Sci Rep . 2018;8:1.29311619
   PubMed Web of Science ®Google Scholar
• Shi L , Zhang Y , Nie K , et al. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI. Magn Reson Imaging . 2019;61:33–40. doi:10.1016/j.mri.2019.05.003 31059768
   PubMed Web of Science ®Google Scholar
• Xu Y , Hosny A , Zeleznik R , et al. Deep learning predicts lung cancer treatment response from serial medical imaging. Clin Cancer Res . 2019;25(11):3266–3275. doi:10.1158/1078-0432.CCR-18-2495 31010833
   PubMed Web of Science ®Google Scholar